BEAM Q4 2020 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

BEAMBeam Therapeutics Inc.

$3B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6,000+0.0% YoY

Gross Profit

-$32M-540750.0% margin

Operating Income

-$41M-679983.3% margin

Net Income

-$95M-1591066.7% margin

EPS (Diluted)

$-1.59

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$32M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$452M

Total Liabilities

$206M

Stockholders' Equity

$246M

Cash & Equivalents

$162M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6,000	$6,000	+0.0%
Gross Profit	-$32M	-$20M	-60.5%
Operating Income	-$41M	-$26M	-54.7%
Net Income	-$95M	-$28M	-242.8%